14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CPRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Catalyst Pharmaceuticals
(Updated on May 02, 2024)

Sell candidate since Apr 24, 2024 Loss -0.66% PDF

The Catalyst Pharmaceuticals stock price fell by -1.18% on the last day (Thursday, 2nd May 2024) from $15.20 to $15.02. During the last trading day the stock fluctuated 4.25% from a day low at $14.84 to a day high of $15.47. The price has fallen in 6 of the last 10 days and is down by -2.09% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -163 thousand shares and in total, 856 thousand shares were bought and sold for approximately $12.86 million.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $14.55 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 9.15% during the next 3 months and, with a 90% probability hold a price between $15.88 and $19.73 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CPRX Signals & Forecast

There are few to no technical positive signals at the moment. The Catalyst Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $15.03 and $15.58. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -11.70%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Catalyst Pharmaceuticals stock

Catalyst Pharmaceuticals finds support from accumulated volume at $14.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.630 (4.25%) between high and low. For the last week, the stock has had daily average volatility of 2.83%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CPRX) For The Upcoming Trading Day Of Friday 3rd

For the upcoming trading day on Friday, 3rd we expect Catalyst Pharmaceuticals to open at $15.11, and during the day (based on 14 day Average True Range), to move between $14.46 and $15.58, which gives a possible trading interval of +/-$0.557 (+/-3.71%) up or down from last closing price. If Catalyst Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 7.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $15.13 (0.73%) than the support at $14.56 (3.06%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Catalyst Pharmaceuticals will release earnings AMC on Wednesday, May 08, 2024.The consensus among the analysts for the expected earnings (EPS) is $0.340. We will update the financials statements for Catalyst Pharmaceuticals, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 4.99% in the first trading day after earnings release.

Is Catalyst Pharmaceuticals stock A Buy?

The Catalyst Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Catalyst Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -4.442 Sell Candidate Unchanged

Predicted Opening Price for Catalyst Pharmaceuticals of Friday, May 3, 2024

Fair opening price May 3, 2024 Current price
$15.11 ( 0.599%) $15.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CPRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 15.74 4.79 %
R2 15.50 3.19 %
R1 15.35 2.20 %
Current price: 15.02
Support S1 14.87 -1.00 %
S2 14.72 -1.99 %
S3 14.48 -3.60 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 17.01 13.25 %
R2 16.03 6.72 %
R1 15.13 0.732 %
Current price 15.02
Support S1 14.56 -3.06%
S2 13.64 -9.19%
S3 13.18 -12.25%

FAQ

What is the symbol for Catalyst Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Catalyst Pharmaceuticals is CPRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Catalyst Pharmaceuticals Stock?
The Catalyst Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Catalyst Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Catalyst Pharmaceuticals Stock?
Catalyst Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Catalyst Pharmaceuticals Stock.

What's the current price of Catalyst Pharmaceuticals Stock?
As of the end of day on the May 02, 2024, the price of an Catalyst Pharmaceuticals (CPRX) share was $15.02.

What is the 52-week high and low for Catalyst Pharmaceuticals Stock?
The 52-week high for Catalyst Pharmaceuticals Stock is $17.77 and the 52-week low is $11.09.

What is the market capitalization of Catalyst Pharmaceuticals Stock?
As of the May 02, 2024, the market capitalization of Catalyst Pharmaceuticals is 1.77B.

When is the next earnings date for Catalyst Pharmaceuticals?
The upcoming earnings date for Catalyst Pharmaceuticals is May 08, 2024.
Click to get the best stock tips daily for free!

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develop... CPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT